D1 Capital Partners L.P. Charles River Laboratories International, Inc. Transaction History
D1 Capital Partners L.P.
- $4.81 Billion
- Q1 2025
A detailed history of D1 Capital Partners L.P. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, D1 Capital Partners L.P. holds 777,489 shares of CRL stock, worth $115 Million. This represents 2.43% of its overall portfolio holdings.
Number of Shares
777,489
Previous 935,820
16.92%
Holding current value
$115 Million
Previous $173 Million
32.26%
% of portfolio
2.43%
Previous 3.8%
Shares
2 transactions
Others Institutions Holding CRL
# of Institutions
648Shares Held
55MCall Options Held
695KPut Options Held
809K-
Vanguard Group Inc Valley Forge, PA6.11MShares$900 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$750 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$632 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$353 Million0.07% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.95MShares$288 Million0.75% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.5B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...